ReviewFrontiers in immunology2023

Predictive short/long-term efficacy biomarkers and resistance mechanisms of CD19-directed CAR-T immunotherapy in relapsed/refractory B-cell lymphomas.

Hao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.